1 2 3 4 5 6 7 8

читать далее ... AM, and EAU recommendations. Eur Urol 2005; 48: 1-4. 14. Morales A, Heaton JPW, Carson CC. Andropause: a misnomer for a true clinical entity. J Urol 2000; 163:705-712. 15. Morley JE, Kaiser FE, Perry HM et al. Longitudinal changes in testosterone, luteinizing hormone and follicle stimulating hormone in healthy older men. Metabolism 1997; 46: 410-421. 16. Kaufman JM, Vermeulen A. Declining gonadal function in elderly men. Baillieres Clin Endocrinol Metab 1997; 11:289-309. 17. Longcope C. Effect of human chorionic gonadotropin on plasma steroid levels in young and old men. Steroids 1973; 21: 583-590. 18. Rubens R, Dhont M, Vermeule A. Further studies on Leydig cell function in old-age. J Clin Endocrinol Metab 1974; 39: 40-45. 19. Harman SM, Tsitouras PD. Reproductive hormones in aging men. 1. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic-gonadotropin. J Clin Endocrinol Metab 1980; 51: 35-40. 20. Harbitz ТВ. Morphometric studies of Leydig cells in elderly men with special reference to histology of prostate. An analysis in an autopsy series. Acta Pathol Microbiol Scand 1973; 81: 301-314. 21. Tsitouras PD, Bulat Т. The aging male reproductive system. Endocrinol Metab Clin North Am 1995:24:297-315. 22. Mulligan Т, Iranmanesh A, Kerzner R et al. Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (nypothalamic and Leydig cell) defects in the healthy aging male gonadotropicaxis. Eur J Endocrinol 1999; 141: 257-266. 23. Giagulli VA, Kaufman JM, Vermeulen A. Patbogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab 1994; 79: 997-1000. 24. Nieschlag E, Behre HM. Clinical uses of testosterone in hypogonadism and other conditions. In Nieschlag E and Behre HM (eds) Testosterone. Action, Deficiency, Substitution. 3rd edn. 2004; Cambridge University Press: 375-403. 25. Мазо ЕБ, Гамидов СИ, Овчинников РИ, Иремашвили ВВ. Этиология, патогенез, диагностика и лечение эректильной дисфункции у пожилых, фарматека 2005; 4/5: 40-45. 26. Morley JE. Impotence. Am J Med 1986; 80: 897-905. 27. Lugg JA, Rajfer J, Gonzalez-Cadavid NF. Dihydrotestosterone is the active androgen in the maintenance of nitric oxidemediated penile erection in the rat. Endocrinology 1995; 136: 1495-1501. 28. Hak AE, Witteman JC, de Jong FH, et al. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 2002; 87: 3632-3639. 29. van den Beld AW, Bots ML, Janssen JA, et al. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003; 157: 25-31. 30. Mills TM, Reilly CM, Lewis RW. Androgens and penile erection: a review. J Androl 1996; 17: 633-638. 31. Morley JE, Kaiser F, Raum WJ, et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth facИсточник: Мазо Е.Б. и др. Русский медицинский журнал. 2006. Т.14. №28. С.2037-2041